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Abstract 
Purpose 
   The respiratory epithelium is exposed to the external environment and functions as a sensor of 
infectious agents to initiate inflammatory response.  Influenza A virus is a critical human respiratory 
pathogen that infects millions of people worldwide in seasonal epidemics. Influenza virus induces 
inflammatory responses as a result of respiratory epithelial cell death.  The pro-inflammatory response 
from respiratory epithelial cells triggers recruitment of immune cells including macrophages and 
neutrophils to remove infectious agents.  These migrated immune cells contribute to excessive 
inflammation.  Thus, the response mechanism of inflammation in respiratory epithelium is crucial for 
understanding the pathogenesis of influenza A virus.  However, the exact cell death mechanism 
responsible for inflammatory responses, which may determine the pathogenesis of influenza A virus, is 
still unclear.   
 
Materials and Methods  
   The number of respiratory epithelial cell death was examined by trypan blue dye exclusion assays and 
DNA fragmentation assays upon influenza virus infection.  The secretion level of pro-inflammatory 
cytokine IL-1β was measured by ELISA.  Indirect immunofluorescence assays were also performed to 
detect apoptotic and pyroptotic cell death using anti-cleaved caspase-3 and anti-ASC antibodies, 
respectively. 
   To identify a novel inflammasome receptor, I examined the proteomic approach of ASC interacting 
proteins and the high-content screening using genome-wide human shRNA library.  The interaction 
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between MxA and endogenous ASC was confirmed by immunoprecipitation using anti-ASC antibody and 
MxA-ASC co-localization was confirmed by immunofluorescence in infected PL16T cells at 36 h post 
infection.   To determine a viral ligand recognized by MxA inflammasome, PL16T cells were transfected 
with viral polymerase subunits and NP, and then treated with poly I:C at 24 h post transfection to express 
MxA.   To analyze the extent of ASC oligomerization, 0.5% Triton X-100-treated PL16T cells were 
crosslinked with 2 mM bis(sulfosuccinimidyl) suberate and analyzed by western blotting with anti-ASC 
antibody.  To examine in vivo function of MxA inflammasome, I used a transgenic mouse carrying the 
entire human Mx locus except MxB gene (hMx-Tg).  Bronchoalveolar lavage fluid (BAL) was collected 
by washing the trachea and lungs twice by injecting a total of 2 ml PBS containing 0.1% BSA, and 
measured IL-1β secretion by ELISA and CD45.2+ total BAL leukocytes by flow cytometry.  To assess  
whether antiviral activity of MxA in hMx-tg mice is dependent on the inflammasome, I generated hMx-Tg 
× Casp1/11−/− mice and monitored their survival against influenza virus infection.  To investigate single 
effects of the MxA inflammasome in respiratory epithelium against influenza virus infection, I generated 
chimeric mice by bone marrow transplantation from Nlrp3−/− mice to hMx-Tg recipient mice to exclude 
the inflammasome response in immune cells, and measured IL-1β secretion and CD45.2+ total BAL 
leukocytes. 
 
Results and Discussion 
    Influenza A virus infection induced apoptosis and pyroptosis in normal or precancerous human 
bronchial epithelial cells.  In PL16T human precancerous respiratory epithelial cells, the number of 
apoptotic cells increased at early phases of infection, but pyroptotic cells were observed at late phases of 
infection. These findings suggest that apoptosis is induced at early phases of viral infection, but the cell 
death pathway is shifted to pyroptosis at late phases of viral infection.  I also found that the type I 
IFN-mediated JAK-STAT signaling pathway promotes the switch from apoptosis to pyroptosis by 
inhibiting apoptosis possibly through the induced expression of Bcl-xL anti-apoptotic gene.  Further, the 
inhibition of JAK-STAT signaling repressed pyroptosis, but enhanced apoptosis in infected PL16T cells, 
suggesting type I IFN signaling pathway triggers pyroptosis but not apoptosis in the respiratory epithelial 
cells in a mutually exclusive manner to initiate pro-inflammatory responses against influenza virus 
infection. 
   Pyroptosis is a caspase-1-dependent inflammatory cell death controlled by inflammasomes, 
multiprotein complexes consisting of caspase-1, apoptosis-associated speck like protein containing a 
CARD (ASC), and cytoplasmic pathogen recognition receptors (PRRs) such as NOD-like receptor (NLR) 
family proteins.  NLR family PYD-containing 3 (NLRP3) inflammasome is crucial for influenza A virus 
pathogenesis through pro-inflammatory cytokine secretion from macrophages.  However, the exact 
mechanism of inflammasome activation in respiratory epithelial cells, especially a sensor molecule for 
influenza virus infection, is largely unknown. 
   Using the high-content shRNA library screening and the LC-MS proteomic analysis, I identified a 
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human myxovirus resistance gene 1 (MxA) as a novel inflammasome receptor in respiratory epithelial 
cells.  MxA recognizes NP viral protein as a pathogen-associated ligand, and oligomerization of MxA is 
required for the inflammasome formation in respiratory epithelial cells but not macrophages.  The 
expression of human MxA in vivo activated the inflammasome formation in bronchiolar epithelial cells 
and protected mice from influenza virus infection by repressing virus spread from the bronchioles to distal 
alveolar regions.   
   Using influenza virus infection as a model, my study reveals the role of MxA on respiratory epithelial 
inflammasome activation.  Not only the MxA expression through poly I:C treatment but also NP viral 
protein as a pathogen-associated ligand is required to trigger the inflammasome activation.  This suggests 
that IL-1β secretion is tightly regulated by under the control of type I/III IFN signaling and the pathogen 
recognition by MxA.  This may guarantee the local pro-inflammatory response in peripheral tissues 
specific for pathogenic infectious agents.  My study also highlights that the function of MxA-mediated 
inflammasome formation is not conserved in mice.  hMx-Tg mice can be a valuable animal model for 
human respiratory epithelium to demonstrate inflammatory response upon virus infection. 
 
